Skip to content
1 WOMEN'S HEALTHWOMEN'S & REPRODUCTIVE HEALTH

Phase II Study of SHR-A1811 for Ultra-Low HER2 Advanced Breast Cancer

Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.

Records
5,000
Last changed
Update schedule
55 1 * * * UTC
Coverage
05/26/2000–10/09/2026
Method
Methodology
Title
Phase II Study of SHR-A1811 for Ultra-Low HER2 Advanced Breast Cancer
Record Date
09/14/2026
Vuga Group
INTERVENTIONAL
Change Status
not-comparable
Recency Days
26.75
Research Attention Score
73.246